TTPAL and esophageal cancer: Consistent with in vitro results, simvastatin treatment showed better therapeutic efficacy in nude mice bearing subcutaneous esophageal cancer xenografts without TTPAL knockdown compared to those with TTPAL knockdown (Fig. 7C-E).